(3-Pyridin-4-yl-[1,2,4]oxadiazol-5-ylmethyl)-carbamic acid tert-butyl ester, 95.0%, 1g

tert-Butyl 3-(4-Methylbenzyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)azetidine-1-carboxylate>95.0%(GC)(T)250mg

3-Amino-pyrazole-4-carboxylic acid amide, 95.0%, 5g

2-(4-Chloro-2-(trifluoromethyl)phenyl)acetonitrile, 95.0%, 5g

1-Boc-4-(4-Iodo-1H-pyrazol-1-yl)piperidine, 95.0%, 5g

100 ml round bottle HDPE white RD 18 cylindrical

N,N-dimethyl-4-{[(prop-2-en-1-yl)amino]methyl}aniline, 95.0%, 10g

3-Methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 5g

8-Bromooctanoic Acid>97.0%(T)25g

3-(Piperidin-4-yl)pyridine dihydrochloride, 98%, 250mg

(R)-3-((tert-Butoxycarbonyl)amino)-3-(2-fluorophenyl)propanoic acid, 95.0%, 1g

Combretastatin A4, 98.0%, 5g

Ethyl 2-amino-5-fluorobenzoate, 97.0%, 1g